Återgå till huvudnavigering
Återgå till sök
Gå direkt till huvudinnehållet
Sortera efter
Keyphrases
Intervention Group
100%
Breast Cancer Treatment
100%
Randomized Controlled Trial
100%
Prostate Radiotherapy
100%
Health Economic Evaluation
100%
Interactive Support
100%
Mobile Electronics
100%
Electronic Patient-reported Outcome (ePRO)
100%
Healthcare Costs
100%
Mean Cost
57%
Intervention Costs
57%
Quality-adjusted Life Years
42%
Acute Inpatient Care
42%
Healthcare
28%
Cancer Treatment
28%
Acute Care
28%
Stockholm
28%
Cost-effectiveness
28%
Common Symptoms
28%
Incremental Cost-effectiveness Ratio
28%
Patient Healthcare
28%
Sweden
14%
University Hospital
14%
Healthcare Organizations
14%
Disease-related
14%
Healthcare Utilization
14%
EORTC QLQ-C30
14%
Radiotherapy
14%
Dyspnea
14%
Early Detection
14%
EQ-5D-3L
14%
Impact on Patients
14%
Prostate Cancer
14%
Non-acute
14%
Societal Perspective
14%
Symptom Management
14%
Supportive Care
14%
In(III)
14%
Economic Evaluation
14%
Oncology Clinic
14%
Administrative Database
14%
Fever
14%
Neoadjuvant Chemotherapy
14%
Digital Intervention
14%
3-way
14%
Cost-utility Analysis
14%
Nonparametric Bootstrapping
14%
Urinary Tract Infection
14%
Payers
14%
Chemotherapy for Breast Cancer
14%
Implementation Costs
14%
Acute Care Utilization
14%
Low Intervention
14%
Randomized Intervention
14%
Nursing and Health Professions
Breast Cancer
100%
Cancer Therapy
100%
Health Care Cost
100%
Patient-Reported Outcome
100%
Prostate Cancer
100%
Economic Evaluation
100%
Health Economics
100%
Health Care
57%
Quality Adjusted Life Year
42%
Health Care Utilization
28%
Incremental Cost-Effectiveness Ratio
28%
University Hospital
14%
Health Care Organization
14%
Dyspnea
14%
Cost Utility Analysis
14%
Symptom Management
14%
Neoadjuvant Chemotherapy
14%
Diseases
14%
Urinary Tract Infection
14%
Bootstrapping
14%
Radiotherapy
14%
Digital Intervention
14%
Medicine and Dentistry
Health Care Cost
100%
Breast Cancer
100%
Randomized Controlled Trial
100%
Cancer Therapy
100%
Prostate Cancer
100%
Patient-Reported Outcome
100%
Health Care
25%
Quality Adjusted Life Year
15%
Health Care Utilization
10%
Cost Effectiveness Analysis
10%
Oncology
5%
Dyspnea
5%
Supportive Care
5%
Symptom Management
5%
Neoadjuvant Chemotherapy
5%
Diseases
5%
Radiation Therapy
5%
Bootstrapping
5%
Urinary Tract Infection
5%